Results 121 to 130 of about 1,740,499 (263)

B cell receptor dependent enhancement of dengue virus infection. [PDF]

PLoS Pathog
Gebo C, Hardy CSC, McElvany BD, Graham NR, Lu JQ, Moradpour S, Currier JR, Friberg H, Gromowski GD, Thomas SJ, Chan GC, Diehl SA, Waickman AT.   +12 more
europepmc   +1 more source

A structural platform for B cell receptor signaling. [PDF]

Cell Res, 2023
Xie W, Wucherpfennig K, Patel DJ.
europepmc   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma. [PDF]

Discov Oncol
Zuo X, Li H, Xie S, Shi M, Guan Y, Liu H, Yan R, Zheng A, Li X, Liu J, Gan Y, Shi H, Chen K, Jia S, Chen G, Liao M, Wang Z, Han Y, Liao B.   +18 more
europepmc   +1 more source

Differential structure-function requirements of the transmembranal domain of the B cell antigen receptor. [PDF]

, 1992
Vedant Parikh, Gail A. Bishop, K J Liu, Burnette Dylan T., Maya R. Ghosh, B S Kim, P W Tucker   +6 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Receptor-mediated elimination of phosphocholine-specific B cells in x-linked immune-deficient mice. [PDF]

, 1991
James J. Kenny, Alan M. Stall, Donna G. Sieckmann, Marinus C. Lamers, Fred D. Finkelman, Louise R. Finch, Dan L. Longo   +6 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Imprints of somatic hypermutation on B-cell receptor immunoglobulins post-infection versus post-vaccination against SARS-CoV-2. [PDF]

Immunohorizons
Vlachonikola E, Pechlivanis N, Karakatsoulis G, Degano M, Psomopoulos F, Crisanti A, Tonon G, Ghia P, Stamatopoulos K, Lavezzo E, Chatzidimitriou A.   +10 more
europepmc   +1 more source

Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation. [PDF]

, 1992
Carlos Márquez, C Martínez, Guido Kroemer, Lisardo Boscá   +3 more
openalex   +1 more source